Coronavirus Epidemiology
Studies in the area of coronavirus epidemiology reported from University of Illinois, Center for Pharmaceutical Biotechnology
Published in Vaccine Weekly, May 28th, 2008
Data detailed in 'Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery' have been presented. "Although the initial outbreaks of the deadly coronavirus that causes severe acute respiratory syndrome (SARS-CoV) were controlled by public health measures, the development of vaccines and antiviral agents for SARS-CoV is essential for improving control and treatment of future outbreaks. One potential target for SARS-CoV antiviral drug development is the 3C-like protease (3CLpro)," scientists writing in the journal Virus Research report.
"This enzyme is an attractive target since it is essential for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-05-28)
More Articles from Vaccine Weekly
- DOE/Brookhaven National Laboratory
Scientists determine drug target for the most potent botulinum neurotoxin - Emory University
Researchers find first conclusive evidence of Alzheimer's-like brain tangles in nonhuman primates - Anthrax
Studies from Harvard University, Medical Department update current data on anthrax - Cancer Gene Therapy
Research in the area of cancer gene therapy reported from M.E. Mossoba and colleagues - Flu Vaccines
Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial - Human Papillomavirus Vaccines
New findings reported from Florida State University, Medical Department describe advances in human papillomavirus vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
